Formulation and Stability of Ataluren Eye Drop Oily Solution for Aniridia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Formulation and Stability of Ataluren Eye Drop Oily Solution for Aniridia
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 1, Pages 7
Publisher
MDPI AG
Online
2020-12-23
DOI
10.3390/pharmaceutics13010007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brinzolamide Dimethyl Sulfoxide In Situ Gelling Ophthalmic Solution: Formulation Optimisation and In Vitro and In Vivo Evaluation
- (2020) Hemant Bhalerao et al. AAPS PHARMSCITECH
- Nonsense suppression induced readthrough of a novel PAX6 mutation in patient‐derived cells of congenital aniridia
- (2020) Xiaoliang Liu et al. Molecular Genetics & Genomic Medicine
- Randomized trial of topical periocular castor oil treatment for blepharitis
- (2020) Alex Muntz et al. Ocular Surface
- Therapeutic potential of castor oil in managing blepharitis, meibomian gland dysfunction and dry eye
- (2020) Emma C Sandford et al. Clinical and Experimental Optometry
- Ataluren Pharmacokinetics in Healthy Japanese and Caucasian Subjects
- (2019) Ronald Kong et al. Clinical Pharmacology in Drug Development
- Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers
- (2019) Marine Roche et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Aniridia and Axenfeld-Rieger Syndrome: Clinical presentations, molecular genetics and current/emerging therapies
- (2019) Paul W. Chrystal et al. EXPERIMENTAL EYE RESEARCH
- Visible light-mediated photodegradation of imidazoline drugs in the presence of Riboflavin: Possible undesired effects on imidazoline-based eye drops
- (2017) Cecilia Challier et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY
- Efficacy of Postnatal In Vivo Nonsense Suppression Therapy in a Pax6 Mouse Model of Aniridia
- (2017) Xia Wang et al. Molecular Therapy-Nucleic Acids
- Recessive and Dominant De Novo ITPR1 Mutations Cause Gillespie Syndrome
- (2016) Sylvie Gerber et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
- (2016) Bijoyita Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects
- (2013) Cheryl Y. Gregory-Evans et al. JOURNAL OF CLINICAL INVESTIGATION
- Clinical study on the application of tacrolimus and DMSO in the treatment of chronic superficial keratitis in dogs
- (2013) I. Balicki POLISH JOURNAL OF VETERINARY SCIENCES
- Ataluren as an Agent for Therapeutic Nonsense Suppression
- (2012) Stuart W. Peltz et al. Annual Review of Medicine
- Aniridia
- (2012) Melanie Hingorani et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Quel choix pour un collyre de corticoïdes : solution ou suspension ?
- (2011) H. Nourry et al. JOURNAL FRANCAIS D OPHTALMOLOGIE
- Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants
- (2010) Carolina Sanmartín-Suárez et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Improving Tenoxicam Solubility and Bioavailability by Cosolvent System
- (2009) Ming-Kung Yeh et al. AAPS PHARMSCITECH
- Comparative clinical trial of castor oil and diclofenac sodium in patients with osteoarthritis
- (2009) B. Medhi et al. PHYTOTHERAPY RESEARCH
- Effect of castor oil emulsion eyedrops on tear film composition and stability
- (2009) Cécile Maïssa et al. Contact Lens & Anterior Eye
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started